[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Racial and ethnic disparities in kidney transplantation for end-stage renal disease: An analysis of the national inpatient sample (NIS) database",
    "section": "",
    "text": "Reference Papers:\n\nIsmail et al. 2024\n\nStudy Objective: Investigate racial and ethnic disparities in the proportion of kidney transplantation recipients among end-stage renal disease (ESRD) patients and evaluate in-hospital outcomes among these recipients.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions for patients aged 18 and older with a diagnosis of ESRD.\nRace Categories:\n\nWhite\nAsian or Pacific Islander\nBlack\nHispanic\nOther\n\nPrimary Outcomes:\n\nProportion of kidney transplantation recipients among ESRD patients\nIn-hospital all-cause mortality\n\nSecondary Outcomes:\n\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nStatistical Analysis: Multiple logistic and linear regression models were used to evaluate independent associations of race and ethnicity with kidney transplantation rates and in-hospital outcomes in ESRD patients, adjusting for, adjusted for:\n\nDemographics: Age, sex, residential income, insurance type, hospital region, hospital bedsize, hospital location, and teaching status.\nMedical History: Coronary artery disease, previous heart failure, obesity, peripheral vascular disease, chronic pulmonary disease, liver disease, and previous stroke or TIA.\nComorbidities: Charlson comorbidity index.\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Racial and ethnic disparities in kidney transplantation for end-stage renal disease: An analysis of the national inpatient sample (NIS) database",
    "section": "",
    "text": "Reference Papers:\n\nIsmail et al. 2024\n\nStudy Objective: Investigate racial and ethnic disparities in the proportion of kidney transplantation recipients among end-stage renal disease (ESRD) patients and evaluate in-hospital outcomes among these recipients.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions for patients aged 18 and older with a diagnosis of ESRD.\nRace Categories:\n\nWhite\nAsian or Pacific Islander\nBlack\nHispanic\nOther\n\nPrimary Outcomes:\n\nProportion of kidney transplantation recipients among ESRD patients\nIn-hospital all-cause mortality\n\nSecondary Outcomes:\n\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nStatistical Analysis: Multiple logistic and linear regression models were used to evaluate independent associations of race and ethnicity with kidney transplantation rates and in-hospital outcomes in ESRD patients, adjusting for, adjusted for:\n\nDemographics: Age, sex, residential income, insurance type, hospital region, hospital bedsize, hospital location, and teaching status.\nMedical History: Coronary artery disease, previous heart failure, obesity, peripheral vascular disease, chronic pulmonary disease, liver disease, and previous stroke or TIA.\nComorbidities: Charlson comorbidity index.\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Racial and ethnic disparities in kidney transplantation for end-stage renal disease: An analysis of the national inpatient sample (NIS) database",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nWhite N = 1,267,5601\nAsian or Pacific Islander N = 128,8301\nBlack N = 1,041,2451\nHispanic N = 527,6651\nOther N = 132,0101\np-value2\nOverall N = 3,097,3101\n\n\n\n\nAge, y\n65 (14)\n66 (15)\n59 (15)\n59 (15)\n61 (15)\n&lt;0.001\n62 (15)\n\n\nSex\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n\n\n    Female\n539,440 (43)\n57,810 (45)\n509,600 (49)\n232,110 (44)\n59,995 (45)\n\n\n1,398,955 (45)\n\n\n    Male\n728,095 (57)\n71,020 (55)\n531,605 (51)\n295,545 (56)\n72,005 (55)\n\n\n1,698,270 (55)\n\n\nResidential income\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n\n\n    $1 - $51,999\n352,660 (28)\n18,885 (15)\n548,405 (53)\n219,395 (42)\n51,420 (41)\n\n\n1,190,765 (39)\n\n\n    $52,000 - $65,999\n362,685 (29)\n26,615 (21)\n228,040 (22)\n137,665 (27)\n29,465 (23)\n\n\n784,470 (26)\n\n\n    $66,000 - $87,999\n305,695 (24)\n36,835 (29)\n158,170 (15)\n108,430 (21)\n25,080 (20)\n\n\n634,210 (21)\n\n\n    $88,000 or more\n228,130 (18)\n45,335 (36)\n90,550 (8.8)\n53,140 (10)\n20,020 (16)\n\n\n437,175 (14)\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n\n\n    Private\n156,400 (12)\n18,760 (15)\n107,955 (10)\n74,640 (14)\n17,000 (13)\n\n\n374,755 (12)\n\n\n    Medicaid\n85,135 (6.7)\n17,905 (14)\n147,605 (14)\n118,135 (22)\n23,615 (18)\n\n\n392,395 (13)\n\n\n    Medicare\n1,001,210 (79)\n90,840 (71)\n769,735 (74)\n327,685 (62)\n88,745 (67)\n\n\n2,278,215 (74)\n\n\n    Other\n23,720 (1.9)\n1,245 (1.0)\n14,950 (1.4)\n6,620 (1.3)\n2,465 (1.9)\n\n\n49,000 (1.6)\n\n\nHospital region\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n\n\n    Midwest\n320,940 (25)\n12,055 (9.4)\n212,525 (20)\n39,645 (7.5)\n18,515 (14)\n\n\n603,680 (19)\n\n\n    Northeast\n233,715 (18)\n19,100 (15)\n158,885 (15)\n66,720 (13)\n25,805 (20)\n\n\n504,225 (16)\n\n\n    South\n505,405 (40)\n19,170 (15)\n582,485 (56)\n205,095 (39)\n46,365 (35)\n\n\n1,358,520 (44)\n\n\n    West\n207,500 (16)\n78,505 (61)\n87,350 (8.4)\n216,205 (41)\n41,325 (31)\n\n\n630,885 (20)\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n\n\n0.017\n\n\n\n\n    Large\n665,330 (52)\n72,730 (56)\n557,015 (53)\n269,080 (51)\n69,005 (52)\n\n\n1,633,160 (53)\n\n\n    Medium\n367,030 (29)\n33,920 (26)\n296,735 (28)\n166,470 (32)\n39,030 (30)\n\n\n903,185 (29)\n\n\n    Small\n235,200 (19)\n22,180 (17)\n187,495 (18)\n92,115 (17)\n23,975 (18)\n\n\n560,965 (18)\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n\n\n&lt;0.001\n\n\n\n\n    Rural\n89,345 (7.0)\n1,595 (1.2)\n47,555 (4.6)\n6,220 (1.2)\n6,825 (5.2)\n\n\n151,540 (4.9)\n\n\n    Urban, non-teaching\n244,835 (19)\n26,355 (20)\n146,800 (14)\n111,240 (21)\n22,450 (17)\n\n\n551,680 (18)\n\n\n    Urban, teaching\n933,380 (74)\n100,880 (78)\n846,890 (81)\n410,205 (78)\n102,735 (78)\n\n\n2,394,090 (77)\n\n\nCharlson comorbidity index\n4.96 (1.77)\n4.98 (1.78)\n4.90 (1.88)\n4.86 (1.71)\n4.86 (1.70)\n&lt;0.001\n4.92 (1.80)\n\n\nCoronary artery disease\n537,565 (42)\n52,135 (40)\n317,990 (31)\n174,930 (33)\n46,510 (35)\n&lt;0.001\n1,129,130 (36)\n\n\nPrevious congestive heart failure\n326,575 (26)\n29,985 (23)\n282,495 (27)\n107,805 (20)\n28,225 (21)\n&lt;0.001\n775,085 (25)\n\n\nObesity\n253,700 (20)\n12,985 (10)\n188,465 (18)\n86,745 (16)\n19,610 (15)\n&lt;0.001\n561,505 (18)\n\n\nPeripheral vascular disease\n173,980 (14)\n17,220 (13)\n127,875 (12)\n54,090 (10)\n12,990 (9.8)\n&lt;0.001\n386,155 (12)\n\n\nChronic pulmonary disease\n372,995 (29)\n22,240 (17)\n252,010 (24)\n80,650 (15)\n25,945 (20)\n&lt;0.001\n753,840 (24)\n\n\nLiver disease\n123,735 (9.8)\n11,915 (9.2)\n86,905 (8.3)\n57,805 (11)\n14,150 (11)\n&lt;0.001\n294,510 (9.5)\n\n\nPrevious stroke/TIA\n170,775 (13)\n19,000 (15)\n180,145 (17)\n67,710 (13)\n15,905 (12)\n&lt;0.001\n453,535 (15)\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#outcomes-tables",
    "href": "quarto/index.html#outcomes-tables",
    "title": "Racial and ethnic disparities in kidney transplantation for end-stage renal disease: An analysis of the national inpatient sample (NIS) database",
    "section": "Outcomes Tables:",
    "text": "Outcomes Tables:\n\nOutcomes of ESRD patients:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nWhite N = 1,267,5601\nAsian or Pacific Islander N = 128,8301\nBlack N = 1,041,2451\nHispanic N = 527,6651\nOther N = 132,0101\np-value2\nOverall N = 3,097,3101\n\n\n\n\nProportion of kidney transplant recipient\n27,370 (2.2)\n4,030 (3.1)\n16,755 (1.6)\n10,830 (2.1)\n2,495 (1.9)\n&lt;0.001\n61,480 (2.0)\n\n\n\n1 n (%)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment\n\n\n\n\n\n\n\n\n\n\nOutcomes of ESRD patients undergoing kidney transplant:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nWhite N = 27,3701\nAsian or Pacific Islander N = 4,0301\nBlack N = 16,7551\nHispanic N = 10,8301\nOther N = 2,4951\np-value2\nOverall N = 61,4801\n\n\n\n\nDied during hospitalization\n150 (0.5)\n15 (0.4)\n95 (0.6)\n55 (0.5)\n25 (1.0)\n0.71\n340 (0.6)\n\n\nLength of stay (days)\n5.0 (3.0 – 7.0)\n5.0 (4.0 – 7.0)\n5.0 (4.0 – 7.0)\n5.0 (4.0 – 7.0)\n5.0 (4.0 – 7.0)\n&lt;0.001\n5.0 (4.0 – 7.0)\n\n\nInflation-adjusted total charge ($)\n232,693 (179,743 – 312,012)\n265,887 (199,431 – 396,772)\n249,269 (190,646 – 332,673)\n275,519 (205,481 – 379,200)\n270,972 (207,241 – 378,876)\n&lt;0.001\n246,963 (188,356 – 337,335)\n\n\n\n1 n (%); Median (Q1 – Q3)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Racial and ethnic disparities in kidney transplantation for end-stage renal disease: An analysis of the national inpatient sample (NIS) database",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nOdds of Receiving Kidney Transplantation\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR (95% CI)1\np-value\n\n\n\n\nRace\n\n\n\n\n\n\n    White\n—\n\n\n\n\n    Asian or Pacific Islander\n1.32 (1.16 to 1.51)\n&lt;0.001\n\n\n    Black\n0.70 (0.64 to 0.76)\n&lt;0.001\n\n\n    Hispanic\n0.95 (0.83 to 1.08)\n0.43\n\n\n    Other\n0.87 (0.73 to 1.04)\n0.12\n\n\nAge, y\n0.97 (0.97 to 0.98)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n    Female\n—\n\n\n\n\n    Male\n1.20 (1.15 to 1.25)\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n    $1 - $51,999\n—\n\n\n\n\n    $52,000 - $65,999\n1.29 (1.21 to 1.38)\n&lt;0.001\n\n\n    $66,000 - $87,999\n1.56 (1.44 to 1.70)\n&lt;0.001\n\n\n    $88,000 or more\n2.13 (1.89 to 2.40)\n&lt;0.001\n\n\nExpected primary payer\n\n\n\n\n\n\n    Private\n—\n\n\n\n\n    Medicaid\n0.15 (0.13 to 0.18)\n&lt;0.001\n\n\n    Medicare\n0.63 (0.59 to 0.66)\n&lt;0.001\n\n\n    Other\n0.44 (0.33 to 0.60)\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n    Midwest\n—\n\n\n\n\n    Northeast\n0.96 (0.76 to 1.23)\n0.76\n\n\n    South\n0.96 (0.76 to 1.21)\n0.72\n\n\n    West\n0.87 (0.65 to 1.15)\n0.31\n\n\nHospital bedsize\n\n\n\n\n\n\n    Large\n—\n\n\n\n\n    Medium\n0.24 (0.18 to 0.33)\n&lt;0.001\n\n\n    Small\n0.12 (0.08 to 0.20)\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n    Rural\n—\n\n\n\n\n    Urban, non-teaching\n4.54 (1.08 to 19.1)\n0.039\n\n\n    Urban, teaching\n98.6 (26.4 to 369)\n&lt;0.001\n\n\nCharlson comorbidity index\n0.62 (0.61 to 0.63)\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.94 (0.88 to 1.00)\n0.036\n\n\nPrevious heart failure\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.40 (0.37 to 0.43)\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.41 (1.31 to 1.52)\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.94 (0.85 to 1.03)\n0.16\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.65 (0.60 to 0.70)\n&lt;0.001\n\n\nLiver disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.28 (1.17 to 1.39)\n&lt;0.001\n\n\nPrevious stroke/TIA\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.66 (0.61 to 0.71)\n&lt;0.001\n\n\n\n1 OR = Odds Ratio, CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nAll-Cause Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR (95% CI)1\np-value\n\n\n\n\nRace\n\n\n\n\n\n\n    White\n—\n\n\n\n\n    Asian or Pacific Islander\n0.96 (0.28 to 3.26)\n0.95\n\n\n    Black\n1.04 (0.54 to 1.99)\n0.91\n\n\n    Hispanic\n1.23 (0.50 to 3.00)\n0.65\n\n\n    Other\n2.24 (0.81 to 6.19)\n0.12\n\n\nAge, y\n1.02 (1.00 to 1.05)\n0.057\n\n\nSex\n\n\n\n\n\n\n    Female\n—\n\n\n\n\n    Male\n1.08 (0.65 to 1.78)\n0.76\n\n\nResidential income\n\n\n\n\n\n\n    $1 - $51,999\n—\n\n\n\n\n    $52,000 - $65,999\n0.59 (0.28 to 1.22)\n0.15\n\n\n    $66,000 - $87,999\n0.65 (0.31 to 1.34)\n0.24\n\n\n    $88,000 or more\n0.66 (0.31 to 1.42)\n0.29\n\n\nExpected primary payer\n\n\n\n\n\n\n    Private\n—\n\n\n\n\n    Medicaid\n0.44 (0.10 to 1.88)\n0.27\n\n\n    Medicare\n0.83 (0.49 to 1.41)\n0.49\n\n\n    Other\n1.34 (0.16 to 11.1)\n0.78\n\n\nHospital region\n\n\n\n\n\n\n    Midwest\n—\n\n\n\n\n    Northeast\n0.95 (0.44 to 2.05)\n0.89\n\n\n    South\n1.07 (0.55 to 2.06)\n0.85\n\n\n    West\n0.55 (0.24 to 1.28)\n0.17\n\n\nHospital bedsize\n\n\n\n\n\n\n    Large\n—\n\n\n\n\n    Medium\n1.80 (0.97 to 3.33)\n0.062\n\n\n    Small\n0.70 (0.21 to 2.26)\n0.55\n\n\nHospital location and teaching status\n\n\n\n\n\n\n    Rural\n—\n\n\n\n\n    Urban, non-teaching\n15,590 (1,781 to 136,481)\n&lt;0.001\n\n\n    Urban, teaching\n12,184 (2,650 to 56,011)\n&lt;0.001\n\n\nCharlson comorbidity index\n1.08 (0.93 to 1.24)\n0.32\n\n\nCoronary artery disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.87 (0.45 to 1.66)\n0.67\n\n\nPrevious heart failure\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n2.09 (0.96 to 4.52)\n0.062\n\n\nObesity\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.63 (0.32 to 1.26)\n0.19\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.77 (0.71 to 4.44)\n0.22\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.56 (0.20 to 1.57)\n0.27\n\n\nLiver disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n13.0 (6.99 to 24.1)\n&lt;0.001\n\n\nPrevious stroke/TIA\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.47 (0.11 to 2.00)\n0.31\n\n\n\n1 OR = Odds Ratio, CI = Confidence Interval"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Racial and ethnic disparities in kidney transplantation for end-stage renal disease: An analysis of the national inpatient sample (NIS) database",
    "section": "Multivariable Linear Regression:",
    "text": "Multivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta (95% CI)1\np-value\n\n\n\n\nRace\n\n\n\n\n\n\n    White\n—\n\n\n\n\n    Asian or Pacific Islander\n-0.40 (-1.0 to 0.24)\n0.22\n\n\n    Black\n0.48 (-0.09 to 1.1)\n0.10\n\n\n    Hispanic\n-0.07 (-0.64 to 0.49)\n0.80\n\n\n    Other\n1.0 (-0.53 to 2.6)\n0.20\n\n\nAge, y\n0.01 (-0.01 to 0.02)\n0.43\n\n\nSex\n\n\n\n\n\n\n    Female\n—\n\n\n\n\n    Male\n0.08 (-0.28 to 0.45)\n0.65\n\n\nResidential income\n\n\n\n\n\n\n    $1 - $51,999\n—\n\n\n\n\n    $52,000 - $65,999\n0.05 (-0.48 to 0.57)\n0.85\n\n\n    $66,000 - $87,999\n0.60 (-0.03 to 1.2)\n0.063\n\n\n    $88,000 or more\n-0.34 (-0.88 to 0.20)\n0.22\n\n\nExpected primary payer\n\n\n\n\n\n\n    Private\n—\n\n\n\n\n    Medicaid\n1.4 (0.31 to 2.5)\n0.012\n\n\n    Medicare\n0.12 (-0.33 to 0.57)\n0.59\n\n\n    Other\n1.0 (-0.64 to 2.6)\n0.23\n\n\nHospital region\n\n\n\n\n\n\n    Midwest\n—\n\n\n\n\n    Northeast\n0.64 (-0.19 to 1.5)\n0.13\n\n\n    South\n-0.11 (-0.85 to 0.64)\n0.78\n\n\n    West\n-0.42 (-1.4 to 0.53)\n0.38\n\n\nHospital bedsize\n\n\n\n\n\n\n    Large\n—\n\n\n\n\n    Medium\n-0.21 (-1.2 to 0.80)\n0.68\n\n\n    Small\n-1.2 (-1.9 to -0.51)\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n    Rural\n—\n\n\n\n\n    Urban, non-teaching\n3.9 (1.3 to 6.6)\n0.004\n\n\n    Urban, teaching\n1.7 (1.0 to 2.4)\n&lt;0.001\n\n\nCharlson comorbidity index\n1.0 (0.79 to 1.3)\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-0.92 (-1.5 to -0.39)\n&lt;0.001\n\n\nPrevious heart failure\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.1 (0.01 to 2.2)\n0.048\n\n\nObesity\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-1.1 (-1.4 to -0.70)\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.98 (-0.57 to 2.5)\n0.21\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-1.8 (-2.4 to -1.3)\n&lt;0.001\n\n\nLiver disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n9.1 (7.0 to 11)\n&lt;0.001\n\n\nPrevious stroke/TIA\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-1.1 (-1.7 to -0.52)\n&lt;0.001\n\n\n\n1 CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta (95% CI)1\np-value\n\n\n\n\nRace\n\n\n\n\n\n\n    White\n—\n\n\n\n\n    Asian or Pacific Islander\n11,507 (-20,249 to 43,264)\n0.48\n\n\n    Black\n19,074 (3,836 to 34,313)\n0.014\n\n\n    Hispanic\n23,533 (4,415 to 42,652)\n0.016\n\n\n    Other\n58,770 (8,642 to 108,898)\n0.022\n\n\nAge, y\n-239 (-726 to 249)\n0.34\n\n\nSex\n\n\n\n\n\n\n    Female\n—\n\n\n\n\n    Male\n-243 (-11,915 to 11,429)\n0.97\n\n\nResidential income\n\n\n\n\n\n\n    $1 - $51,999\n—\n\n\n\n\n    $52,000 - $65,999\n3,452 (-11,577 to 18,481)\n0.65\n\n\n    $66,000 - $87,999\n20,766 (-2,917 to 44,449)\n0.086\n\n\n    $88,000 or more\n11,033 (-9,360 to 31,426)\n0.29\n\n\nExpected primary payer\n\n\n\n\n\n\n    Private\n—\n\n\n\n\n    Medicaid\n23,654 (-15,660 to 62,969)\n0.24\n\n\n    Medicare\n-6,185 (-22,172 to 9,803)\n0.45\n\n\n    Other\n39,514 (-91,359 to 170,388)\n0.55\n\n\nHospital region\n\n\n\n\n\n\n    Midwest\n—\n\n\n\n\n    Northeast\n29,259 (-13,520 to 72,038)\n0.18\n\n\n    South\n-11,813 (-39,060 to 15,435)\n0.39\n\n\n    West\n107,956 (34,832 to 181,080)\n0.004\n\n\nHospital bedsize\n\n\n\n\n\n\n    Large\n—\n\n\n\n\n    Medium\n-28,849 (-83,327 to 25,628)\n0.30\n\n\n    Small\n11,390 (-35,667 to 58,447)\n0.63\n\n\nHospital location and teaching status\n\n\n\n\n\n\n    Rural\n—\n\n\n\n\n    Urban, non-teaching\n190,757 (66,099 to 315,415)\n0.003\n\n\n    Urban, teaching\n103,351 (63,825 to 142,878)\n&lt;0.001\n\n\nCharlson comorbidity index\n34,457 (24,559 to 44,355)\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-23,532 (-38,909 to -8,155)\n0.003\n\n\nPrevious heart failure\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n40,681 (3,239 to 78,123)\n0.033\n\n\nObesity\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-17,857 (-32,623 to -3,092)\n0.018\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n22,620 (-16,973 to 62,212)\n0.26\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-56,345 (-75,312 to -37,378)\n&lt;0.001\n\n\nLiver disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n261,235 (199,459 to 323,011)\n&lt;0.001\n\n\nPrevious stroke/TIA\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-45,441 (-67,943 to -22,938)\n&lt;0.001\n\n\n\n1 CI = Confidence Interval"
  }
]